Skip to main content

Avapag 20 mg ( Avatrombopag)

Introduction

Understanding the manufacturer of a medicine is an important part of responsible pharmaceutical product information. Patients, healthcare professionals, pharmacists and other readers may want to know which company produces a medicine, where it is manufactured and whether the product has appropriate regulatory authorization.

Avapag 20 mg is identified on this website as a product containing avatrombopag, an active ingredient belonging to the thrombopoietin receptor agonist class. Avatrombopag helps stimulate platelet production in the bone marrow and is used for specific forms of thrombocytopenia.

However, the manufacturer of the specific Avapag product has not been independently confirmed for this website. Therefore, we do not attribute Avapag to a particular pharmaceutical company or claim a manufacturing location without supporting product documentation.

Manufacturer information should always be established through the product packaging, official product literature, manufacturing documentation or applicable regulatory records.

Who Manufactures Avapag 20 mg?

The manufacturer of Avapag 20 mg requires product-specific verification.

A medicine’s brand name and active ingredient do not independently establish which company manufactures it. Several pharmaceutical companies may produce medicines containing the same active ingredient, and different brands may have different manufacturers, distributors and marketing authorization holders.

For Avapag, the following details should be checked before a manufacturer is identified:

  • Full pharmaceutical company name.
  • Manufacturing facility and country.
  • Product registration or authorization details.
  • Marketing authorization holder, where applicable.
  • Product packaging and labeling.
  • Batch or lot identification.
  • Manufacturing and expiry dates.
  • Official patient information leaflet.

Until these details are verified, the manufacturer should be described as not independently confirmed rather than assigning the product to an unverified company.

Understanding the Pharmaceutical Company Behind a Medicine

A pharmaceutical product may involve several organizations during development, manufacturing, authorization and distribution. These organizations can have different responsibilities.

Product Manufacturer

The product manufacturer is the company or facility responsible for producing the medicine or carrying out specified manufacturing operations.

Manufacturing activities may include:

  • Production of the pharmaceutical formulation.
  • Processing of the active ingredient.
  • Tablet manufacturing, where applicable.
  • Quality-control testing.
  • Packaging and labeling.
  • Batch documentation.
  • Compliance with applicable manufacturing standards.

The manufacturer identified on a medicine package should be checked against the relevant product documentation.

Marketing Authorization Holder

A marketing authorization holder is the organization responsible for holding a medicine’s marketing authorization in a particular regulatory jurisdiction.

This organization may be different from the company that physically manufactures the medicine.

Its responsibilities may include maintaining regulatory documentation, managing product information and fulfilling applicable pharmacovigilance and regulatory obligations.

Distributor or Supplier

A distributor or supplier is involved in making a pharmaceutical product available through a supply chain.

A distributor may purchase products from manufacturers or authorized suppliers and distribute them to pharmacies, hospitals or other permitted purchasers.

A distributor should not automatically be described as the manufacturer.

Brand Owner

A brand owner is the organization associated with a particular product name or brand identity.

The brand owner, manufacturer, distributor and marketing authorization holder may be separate organizations. Their identities should not be treated as interchangeable.

Understanding Avatrombopag

Avatrombopag is the active ingredient identified for Avapag 20 mg. It belongs to the thrombopoietin receptor agonist class of medicines.

The active ingredient works by stimulating thrombopoietin receptors in the bone marrow. This supports the development and maturation of megakaryocytes, which are responsible for producing platelets.

Platelets play an essential role in normal blood clotting. When platelet counts are too low, patients may experience increased bruising or bleeding, depending on the severity and underlying cause.

Avatrombopag has established uses in specified adult patients with:

  • Thrombocytopenia associated with chronic liver disease who are scheduled to undergo a procedure.
  • Chronic immune thrombocytopenia in adults who have had an insufficient response to previous treatment.

These are active-ingredient-level medical uses. They should not be interpreted as confirmation of Avapag-specific regulatory authorization in every country.

Reference Product and Brand Distinction

Doptelet is a recognized reference brand containing avatrombopag. It provides an established example of an avatrombopag medicine with documented prescribing information.

However, the existence of Doptelet does not establish that Doptelet’s manufacturer also manufactures Avapag.

Products containing the same active ingredient may differ in:

  • Brand ownership.
  • Manufacturing company.
  • Manufacturing location.
  • Pharmaceutical formulation.
  • Packaging.
  • Product registration.
  • Country-specific authorization.
  • Distribution arrangements.

For this reason, Avapag should be assessed using its own packaging and product documentation. Information belonging to another avatrombopag brand should not be presented as an Avapag-specific fact.

Pharmaceutical Manufacturing and Quality Considerations

Quality is an important consideration in the production of prescription medicines. Pharmaceutical manufacturing involves processes designed to ensure that products meet established quality requirements.

Depending on the product and applicable regulatory requirements, quality-related activities may include:

Raw Material Control

Pharmaceutical manufacturers must use materials that meet appropriate quality specifications. Active ingredients and other materials should be evaluated according to established procedures.

Manufacturing Process Control

Manufacturing processes should be controlled to support consistency between production batches. Appropriate procedures help reduce the risk of contamination, production errors and unacceptable variation.

Quality-Control Testing

Quality-control testing may assess product characteristics such as identity, strength, purity and other relevant specifications.

Packaging and Labeling

Packaging should provide accurate product identification and essential information. Labels may include the medicine name, active ingredient, strength, batch number, expiry date, storage instructions and manufacturer details.

Batch Documentation

Batch records support traceability and help establish the history of a particular production batch.

These general quality principles should not be interpreted as confirmation that a particular Avapag product has undergone a specific test or holds a particular certification. Such claims require product-specific documentation.

How to Verify the Manufacturer of Avapag

Patients and healthcare professionals should check the actual product packaging and relevant documentation when verifying manufacturer details.

Important information to review includes:

InformationWhat to check
Product nameAvapag
Active ingredientAvatrombopag
Stated strength20 mg
Dosage formConfirm from packaging
ManufacturerConfirm the printed company name
Manufacturing countryCheck product labeling
Batch numberCheck the batch or lot identification
Manufacturing dateReview the printed date, if provided
Expiry dateConfirm that the product is within its expiry period
Registration detailsCheck applicable country-specific documentation
Package leafletReview the supplied product information

If information is missing, inconsistent or unclear, the product should be referred to an appropriate pharmacist, supplier or regulatory authority for verification.

A website description alone cannot establish the authenticity of a physical medicine package.

Our Commitment to Accurate Manufacturer Information

Avapag.com aims to present clear and responsible information about Avapag 20 mg and its active ingredient, avatrombopag.

We recognize that accurate manufacturer information is important for product identification and transparency. For this reason, we avoid publishing unverified company names, manufacturing locations, certifications or regulatory claims.

When reliable product documentation becomes available, the manufacturer information can be reviewed and updated accordingly.

Our content distinguishes between general information about avatrombopag and information specifically verified for Avapag. This distinction helps readers understand which details relate to the active ingredient and which details require confirmation for the individual branded product.

Frequently Asked Questions About the Avapag Manufacturer

Who manufactures Avapag 20 mg?

The manufacturer of Avapag 20 mg has not been independently confirmed for this website. The company name should be checked using the product packaging and official documentation.

What is the active ingredient in Avapag?

The active ingredient identified for Avapag is avatrombopag, with a stated strength of 20 mg.

Is Avapag manufactured by the same company as Doptelet?

This has not been established. Doptelet is a reference brand containing avatrombopag, but its manufacturer should not automatically be identified as the manufacturer of Avapag.

What is the difference between a manufacturer and a distributor?

A manufacturer produces the medicine or performs specified manufacturing operations. A distributor supplies or distributes the medicine through the pharmaceutical supply chain. These organizations may be different.

What is a marketing authorization holder?

A marketing authorization holder is the organization responsible for holding a medicine’s marketing authorization in a particular country or regulatory region. It may be different from the physical manufacturer.

How can I identify the Avapag manufacturer?

Check the product package, labeling, package leaflet and applicable regulatory documentation. Look for the full company name and manufacturing information.

Why is manufacturer information important?

Manufacturer information helps identify the organization responsible for producing a medicine and supports product traceability, quality assessment and supply-chain transparency.

Does Avapag contain avatrombopag?

Avapag is identified on this website as a product containing avatrombopag 20 mg. The specific package should always be checked to confirm its contents and strength.

Is Avapag approved in every country?

Regulatory authorization is country-specific. The authorization status of Avapag must be confirmed with the relevant national regulatory authority.

Can manufacturer information be updated?

Yes. Manufacturer details can be updated when reliable product packaging, official company documentation or regulatory records become available.

Important Information

The manufacturer of Avapag 20 mg has not been independently verified for this website. No specific pharmaceutical company, manufacturing facility, certification or regulatory authorization is claimed.

Readers should verify the product identity and manufacturer through appropriate documentation before relying on product-specific claims.